FDG PET in the clinical evaluation of sarcoidosis with bone lesions-Reference-Cited by-同舟云学术

FDG PET in the clinical evaluation of sarcoidosis with bone lesions

Published:2000-08 Issue:4 Volume:14 Page:311-313
ISSN:0914-7187
Container-title:Annals of Nuclear Medicine
language:en
Short-container-title:Ann Nucl Med

Author:

Kobayashi Atsushi,Shinozaki Tetsuya,Shinjyo Yasuaki,Kato Katsuya,Oriuchi Noboru,Watanabe Hideomi,Takagishi Kenji

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02988216.pdf

Reference14 articles.

1. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients.Q J Med 52 (208): 525–533, 1983.

2. Pietinalho A, Hiraga Y, Hosoda Y, Löfroos A-B, Yamaguchi M, Selroos O. The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study.Sarcoidosis 12: 61–67, 1995.

3. Gunter B. Sarcoidosis.Orthopedics 18: 214–218, 1995.

4. Alavi A, Buchpiguel CA, Loessner A. Is there a role for FDG PET imaging in the management of patients with sarcoidosis?J Nucl Med 35: 1650–1652, 1994.

5. Pino JGD, Ulloa AD, Lovic A, Relea MF. Sarcoidosis of the hand and wrist: a report of two cases.J Hand Surg 22A: 942–945, 1997.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disseminated Multi-system Sarcoidosis Mimicking Metastases on 18F-FDG PET/CT;Malecular Imaging and Radionuclide Therapy;2018-06-08

2. The clinical conundrum of diagnosing and treating systemic sarcoidosis in a high TB burden area;BMJ Case Reports;2017-05-12

3. Additional Heparin Preadministration Improves Cardiac Glucose Metabolism Suppression over Low-Carbohydrate Diet Alone in 18F-FDG PET Imaging;Journal of Nuclear Medicine;2015-12-10

4. Osseous Sarcoidosis;JBJS Reviews;2015-04-21

5. Central skeletal sarcoidosis: a case report with sustained remission only on methotrexate, and a literature review on the imaging approach, treatment, and assessment of disease activity;MOD RHEUMATOL;2013